Candida glabrata: an important fungal pathogen for the 21st century

Fidel, 1999, Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans, Clin. Microbiol. Rev., 12, 80, 10.1128/CMR.12.1.80 Kwon-Chung, 1992, 280 Whelan, 1984, Auxotrophic variants of Torulopsis glabrata, FEMS Microbiol. Lett., 24, 1, 10.1111/j.1574-6968.1984.tb01232.x Khattak, 1992, Clamped homogenous electric field gel electrophoresis typing of Torulopsis glabrata isolates causing nosocomial infections, J. Clin. Microbiol., 30, 2211, 10.1128/JCM.30.8.2211-2215.1992 Vazquez, 1998, Nosocomial Candida glabrata colonization: an epidemiologic study, J. Clin. Microbiol., 36, 421, 10.1128/JCM.36.2.421-426.1998 Sanson, 2000, Typing of Candida glabrata in clinical isolates by comparative sequence analysis of the cytochrome c oxidase subunit 2 gene distinguishes two clusters of strains associated with geographical sequence polymorphisms, J. Clin. Microbiol., 38, 227, 10.1128/JCM.38.1.227-235.2000 Vazquez, J. Unpublished observations. Sandven, 2000, Epidemiology of candidemia, Rev. Iberoam. Micol., 17, 73 Sobel, 1995, Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis, Am. J. Obstet. Gynecol., 172, 1263, 10.1016/0002-9378(95)91490-0 Martins, 1997, Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients, Clin. Infect. Dis., 25, 843, 10.1086/515554 Goswami, 2000, Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status, J. Infect., 41, 162, 10.1053/jinf.2000.0723 Reagan, 1990, Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe, J. Clin. Microbiol., 28, 2733, 10.1128/JCM.28.12.2733-2738.1990 Odds, 1988, 104 Klotz, 1983, Adherence and penetration of vascular endothelium by Candida yeasts, Infect. Immun., 42, 374, 10.1128/IAI.42.1.374-384.1983 Csank, 2000, Candida glabrata displays pseudohyphal growth, FEMS Microbiol. Lett., 189, 115, 10.1111/j.1574-6968.2000.tb09216.x Chakrabarti, 1991, In vitro proteinase production by Candida species, Mycopathologia, 114, 163, 10.1007/BF00437209 Hazen, 1986, Influence of growth conditions on cell surface hydrophobicity of Candida albicans and Candida glabrata, Infect. Immun., 54, 269, 10.1128/IAI.54.1.269-271.1986 Lachke, 2000, Phenotypic switching in Candida glabrata involves phase-specific regulation of the metallothionein gene MT-II and the newly discovered hemolysin gene HLP, Infect. Immun., 68, 884, 10.1128/IAI.68.2.884-895.2000 Steele, 2000, Growth inhibition of Candida by human oral epithelial cells, J. Infect. Dis., 182, 1479, 10.1086/315872 Filler, 1995, Penetration and damage of endothelial cells by Candida albicans, Infect. Immun., 63, 976, 10.1128/IAI.63.3.976-983.1995 Mendling, 1996, Immunological investigations in vaginal mycoses, Mycoses, 39, 177, 10.1111/j.1439-0507.1996.tb00122.x Hickey, 1983, Disseminated Candida glabrata: report of a uniquely severe infection and a literature review, Am. J. Clin. Pathol., 80, 724, 10.1093/ajcp/80.5.724 Brawner, 1984, Variability in expression of a cell surface determinant on Candida albicans as evidenced by an agglutinating monoclonal antibody, Infect. Immun., 43, 966, 10.1128/IAI.43.3.966-972.1984 De Bernardis, 1996, Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus, Infect. Immun., 64, 466, 10.1128/IAI.64.2.466-471.1996 Fidel, 1996, A murine model of Candida glabrata vaginitis, J. Infect. Dis., 173, 425, 10.1093/infdis/173.2.425 Fidel, 1997, Efficacy of D0870 treatment of experimental Candida vaginitis, Antimicrob. Agents Chemother., 41, 1455, 10.1128/AAC.41.7.1455 Vazquez, 1997, Epidemiologica: overview of resistance to oral antifungal agents in the immunocompromised host, Excerpta. Med. Int. Congr. Ser., 1997, 1 Sangeorzan, 1994, Epidemiology of oral candidiasis in HIV infected patients: colonization, infection, treatment, and emergence of fluconazole resistance, Am. J. Med., 97, 339, 10.1016/0002-9343(94)90300-X Murray, 1997, Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients, Clin. Ther., 19, 1, 10.1016/S0149-2918(97)80131-2 Hay, 1990, Overview of studies of fluconazole in oropharyngeal candidiasis, Rev. Infect. Dis., 12, 334, 10.1093/clinids/12.Supplement_3.S334 Diamond, 1991, The growing problem of mycoses in patients infected with the human immunodeficiency virus, Rev. Infect. Dis., 13, 480, 10.1093/clinids/13.3.480 Sobel, 1998, Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations, Am. J. Obstet. Gynecol., 178, 203, 10.1016/S0002-9378(98)80001-X Geiger, 1995, Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, Candida glabrata, and no Candida, Genitourin. Med., 71, 304 Horowitz, 1992, Evolving pathogens in vulvovaginal candidiasis: implications for patient care, J. Clin. Pharmacol., 32, 248, 10.1002/j.1552-4604.1992.tb03833.x Spinillo, 1995, Torulopsis glabrata vaginitis, Obstet. Gynecol., 85, 993, 10.1016/0029-7844(95)00047-U Sobel, 1986, Recurrent vulvo-vaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy, N. Engl. J. Med., 315, 1455, 10.1056/NEJM198612043152305 Schuman, 1997, Weekly fluconazole for the treatment of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial, Ann. Intern. Med., 126, 689, 10.7326/0003-4819-126-9-199705010-00003 Schuman, 1998, Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection, Clin. Infect. Dis., 27, 1161, 10.1086/514979 Lynch, 1994, Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates, J. Med. Vet. Mycol., 32, 267, 10.1080/02681219480000341 Redondo-Lopez, 1990, Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents, Obstet. Gynecol., 76, 651 Sobel, 1997, Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy, Clin. Infect. Dis., 24, 649, 10.1093/clind/24.4.649 Rivett, 1986, Urinary candidiasis: a prospective study in hospitalized patients, Urol. Res., 14, 183, 10.1007/BF00441110 Wise, 1993, Fungal infections of the genitourinary system, J. Urol., 149, 1377, 10.1016/S0022-5347(17)36396-6 Sobel, 2000, Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo, Clin. Infect. Dis, 30, 19, 10.1086/313580 Kauffman, 2000, Prospective multicenter surveillance study of funguria in hospitalized patients, Clin. Infect. Dis., 30, 14, 10.1086/313583 Odds, 1988, 89 Komshian, 1989, Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome, Rev. Infect. Dis., 11, 379, 10.1093/clinids/11.3.379 Fraser, 1992, Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality, Clin. Infect. Dis., 15, 414, 10.1093/clind/15.3.414 Anaissie, 1996, Management of invasive candidal infections: result of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature, Clin. Infect. Dis., 23, 964, 10.1093/clinids/23.5.964 Rex, 1994, A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia, N. Engl. J. Med., 331, 1325, 10.1056/NEJM199411173312001 Rex, 1995, Resistance of Candida species to fluconazole, Antimicrob. Agents Chemother., 39, 1, 10.1128/AAC.39.1.1 Wingard, 1995, Importance of Candida species other than C. albicans as pathogens in oncology patients, Clin. Infect. Dis., 20, 115, 10.1093/clinids/20.1.115 Gallis, 1990, Amphotericin B: 30 years of clinical experience, Rev. Infect. Dis., 12, 308, 10.1093/clinids/12.2.308 Shepherd, 1985, Candida albicans: biology, genetics, and pathogenicity, Ann. Rev. Microbiol., 39, 579, 10.1146/annurev.mi.39.100185.003051 Vanden-Bosche, 1994, Mechanisms and clinical impact of antifungal resistance, J. Med. Vet. Mycol., 32, 189, 10.1080/02681219480000821 Defontaine, 1999, In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata, J. Med. Microbiol., 48, 663, 10.1099/00222615-48-7-663 Parkinson, 1995, Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata, Antimicrob. Agents. Chemother., 39, 1696, 10.1128/AAC.39.8.1696 Phillips, 1996, Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility, AIDS, 10, 1369, 10.1097/00002030-199610000-00009 Koul, 1999, Effects of voriconazole on Candida glabrata in vitro, J. Antimicrob. Chemother., 44, 109, 10.1093/jac/44.1.109